Abstract:OBJECTIVE:The purpose of this investigation was to identify the novel genetic mutations in patients with a congenital atrial septal defect (ASD).METHODS:Clinical data and blood specimens from a total of 12 unrelated ASD pedigrees and a cohort of 168 unrelated subjects with sporadic ASD were collected and evaluated in contrast to 200 healthy individuals. The whole exons and partial flanking introns of NKX2-5 gene were amplified by polymerase chain reaction and sequenced using the di-deoxynucleotide chain termination approach. The acquired sequences were aligned with those publicized in GenBank by the aid of programme BLAST to identify the sequence variations. The software ClustalW was applied for analysis of the conservative of the altered amino acids.RESULTS:A novel heterozygous mutation of NKX2-5 gene, i.e., a substitution of thymine for cytosine at nucleotide 536, predicting the conversion of serine into phenylalanine at amino acid residue 179, was identified initially in a proband. The same missense mutation was thereafter detected in other 3 affected members of the identical family but neither in the healthy members of the kindred nor in the 200 normal controls. A cross-species alignment of the protein sequences encoded by NKX2-5 gene displayed that the mutated amino acid was highly conserved evolutionarily. No mutation of NKX2-5 gene was observed in the other 11 ASD pedigrees or in 168 patients with sporadic ASD. Additionally, a common synonymous single nucleotide polymorphism, a transition of adenine (A) into guanine (G) at nucleotide 63, was found in NKX2-5 gene. However, there were no significant differences in the prevalence of alleles A and G between ASD patients and healthy controls (chi(2) = 2.8641, P = 0.0906).CONCLUSION:A novel mutation of NKX2-5 gene identified in an ASD family suggests that mutated NKX2-5 gene is responsible for familial ASD.

Identification and functional analysis of genetic variants of <i>ISL1</i> gene promoter in human atrial septal defects

Identification and functional analysis of genetic variants of ISL1 gene promoter in human atrial septal defects.

Identification and Functional Analysis of Variants in ISL1 Promoter from Patients with Isolated Atrial Septal Defects

Identification of Variants of ISL1 Gene Promoter and Cellular Functions in Isolated Ventricular Septal Defects

Genetic Analysis of Variants of the MYH6 Gene Promoter in Congenital Atrial Septal Defects

Genetic Variants of CITED2 Gene Promoter in Human Atrial Septal Defects: Case-Control Study and Cellular Functional Verification

Genetic Variants of ISL1 Gene Promoter Identified from Congenital Tetralogy of Fallot Patients Alter Cellular Function Forming Disease Basis

Identification and Functional Analysis of Variants of MYH6 Gene Promoter in Isolated Ventricular Septal Defects

Molecular and cellular role of variants of the promoter region of HAND1 gene in sporadic and isolated ventricular septal defect

Variants and Cellular Functional Verification of CITED2 Gene Promoter Region in Patients with Atrial Septal Defect

A novel GATA-binding protein 4 gene variation associated with familial atrial septal defect

[Mutation of NKX2-5 Gene in Patients with Atrial Septal Defect].

Predisposition to Atrioventricular Septal Defects May Be Caused by SOX7 Variants That Impair Interaction with GATA4

[Novel GATA4 Mutations Identified in Patients with Congenital Atrial Septal Defects].

Three Rare Variants of SOX7 Impairing Its Interaction with GATA4 May Be a Predisposing Factor to Complete AVSD

Novel NKX2-5 Mutations in Patients With Familial Atrial Septal Defects

Identification of LBX2 As a Novel Causal Gene of Atrial Septal Defect

Novel Genetic Variants of Sporadic Atrial Septal Defect (ASD) in a Chinese Population Identified by Whole-Exome Sequencing (WES)

ISL1 Loss-of-function Mutation Contributes to Congenital Heart Defects

Genetic Variations of ISL1 Associated with Human Congenital Heart Disease in Chinese Han People

A New ISL1 Loss-of-Function Mutation Predisposes to Congenital Double Outlet Right Ventricle.